Are you struggling to find the ideal animal model for your patient derived xenograft (PDX) work? Explore the differences in performance in our new B-NDG model. This triple immunodeficient mouse has been successfully used to establish more than 170 PDX models across a variety of tumor types, including solid and hematological malignancies.
Watch our webinar where you will:
- Review B-NDG model development, characteristics, and research uses
- Compare differences between the B-NDG and JAX® NSG™ mice
- Examine growth of B-NDG vs NSG™ models in CDX tumor studies
- Evaluate performance of B-NDG vs NSG™ models in PDX tumor studies
Complete the form to access our on-demand webinar.
